EDTUTC-4 New YorkLog in Sign up

ZBIO
Zenas BioPharma, Inc. Common Stock
stockNASDAQ

Market OpenOct 5, 2026 11:50:39 AM EDT

28.11USD-0.654%(-0.18)125,532

27.96Bid28.24Ask0.28Spread

ZBIO News

Day breaks

08:09 AM EDTH.C. Wainwright reiterates Zenas Biopharma stock rating ahead of PDUFA ·

Investing.com

06:44 AM EDTGuggenheim reiterates Zenas Biopharma stock rating on IgG4-RD outlook ·

Investing.com

12:03 AM EDTZenas BioPharma, Inc. (ZBIO) Discusses Obexelimab Prelaunch Strategy and Commercial Opportunity in IgG4-Related Disease Transcript ·

Seeking Alpha

07:14 AM EDTCan Zenas BioPharma’s (ZBIO) Clinical Pipeline Justify Its Heavy Cash Burn? ·

Insider Monkey

07:05 AM EDTZenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026 ·

GlobeNewswire Inc.

04:15 PM EDTZenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) ·

GlobeNewswire Inc.

08:34 AM EDTZenas BioPharma at H.C. Wainwright conference: pipeline nears key tests ·

Investing.com

09:01 PM EDTZenas BioPharma, Inc. (ZBIO) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha